Viewing Study NCT00284934

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2026-03-23 @ 10:16 AM
Study NCT ID: NCT00284934
Status: COMPLETED
Last Update Posted: 2011-05-02
First Post: 2006-01-30
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients
Sponsor: Novartis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose optimization View
None immune suppressive regimen View
None enteric-coated mycophenolate sodium View
None EC-MPS View
None renal transplantation View
None kidney View
None transplant View
None maintenance patients View
None Renal transplantation in maintenance View